August 29th 2025
Teva announced approval of the generic formulation of Saxenda, which could help expand access to the extremely popular class of antiobesity medications.
High-Fat Diets Linked to Stage III Colon Cancer Recurrence
August 14th 2007BOSTON -- After curative surgery and adjuvant chemotherapy for stage III colon cancer, patients who ate a high-fat diet were more likely to have a recurrence than those who ate a so-called prudent diet, researchers here reported.